Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)
| 1.46 BATS BZX Real-Time Price As of 9:55am ET |  -0.03 / -2.01%Today’s Change | 1.23 Today|||52-Week Range 10.22 | -74.76% Year-to-Date |
Latest SONN News | Press Releases
No recent news for Sonnet Biotherapeutics Holdings Inc.
Today’s Trading
| Previous close | 1.49 |
| Today’s open | 1.46 |
| Day’s range | 1.46 - 1.46 |
| Volume | 5 |
| Average volume (3 months) | 285,678 |
| Market cap | $8.1M |
Data as of 9:55am ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +85.38% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 30.76 |
| Price/Book | 0.31 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 30, 2022 |
| EPS forecast (this quarter) | -$1.51 |
| Annual revenue (last year) | $483.6K |
| Annual profit (last year) | -$25.0M |
| Net profit margin | -5,165.97% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
